Hepatitis C Virus NS5A Inhibitor
- Name
- Hepatitis C Virus NS5A Inhibitor
- Accession Number
- DBCAT003507
- Description
Not Available
- Drugs
Drug Drug Description Ledipasvir A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. Daclatasvir A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. Ombitasvir A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. Elbasvir An antiviral and NS5A inhibitor used to treat hepatitis C infections. Velpatasvir A NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis. Pibrentasvir A Hepatitis C NS5A inhibitor used to treat Hepatitis C. - Drugs & Drug Targets